You just read:

Amgen Provides Update On Status Of Parsabiv™ (Etelcalcetide) New Drug Application (NDA) Submitted To The U.S. Food And Drug Administration (FDA)

News provided by

Amgen

Aug 24, 2016, 18:03 ET